Results 211 to 220 of about 442,293 (268)
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Functional analysis of a novel variant in the <i>COL5A1</i> gene in a Polish patient with the classical type of Ehlers-Danlos syndrome. [PDF]
Junkiert-Czarnecka A +9 more
europepmc +1 more source
A novel variant leads to WT1-related nephrotic syndrome and differences of sex development: a case report. [PDF]
Gao S +10 more
europepmc +1 more source
Corrigendum: A novel variant in <i>CLCN7</i> regulates the coupling of angiogenesis and osteogenesis. [PDF]
Peng H, He HB, Wen T.
europepmc +1 more source
Infertility Due to a Novel Variant of a Balanced Y;1 Translocation: A Case Report. [PDF]
Magnuson S +3 more
europepmc +1 more source
A Novel Variant of ARID1B-Related Coffin-Siris Syndrome in a Saudi Girl: A Case Report. [PDF]
Alquraishi AS +3 more
europepmc +1 more source
Novel variant in <i>PNPLA6</i> gene causes Oliver-McFarlane syndrome in a Chinese family: 13 years follow-up. [PDF]
Xiao P +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Variants of the Novel Coronavirus
Journal of Clinical Case Reports and Studies, 2022The novel coronavirus had emerged in 2019 from the Hubei province in China. Now the world is facing the third and fourth waves of the pandemic caused by this virus. These are due to the new mutants and variants of the virus that have emerged over time due to various reasons. It is important to keep oneself updated about these mutants and variants.
Sayan Bhattacharyya +2 more
openaire +1 more source
Response to: Naming a novel hemoglobin variant
Journal of Chromatography B, 2014[No abstract available]
Wieland, Heinrich +2 more
openaire +3 more sources
Diabetes, 2001
Glutamine:fructose-6-phosphate amidotransferase(GFAT) is the rate-limiting enzyme of the hexosamine synthesis pathway. Products of this pathway have been implicated in insulin resistance and glucose toxicity. GFAT1 is ubiquitous, whereas GFAT2 is expressed mainly in the central nervous system.
John E. DeHaven +3 more
openaire +1 more source
Glutamine:fructose-6-phosphate amidotransferase(GFAT) is the rate-limiting enzyme of the hexosamine synthesis pathway. Products of this pathway have been implicated in insulin resistance and glucose toxicity. GFAT1 is ubiquitous, whereas GFAT2 is expressed mainly in the central nervous system.
John E. DeHaven +3 more
openaire +1 more source

